Search results
Olivia Munn, 43, Underwent Hysterectomy, Froze Her Eggs Amid Breast Cancer Battle
Women's Health via AOL· 3 days agoOlivia Munn opened up about being diagnosed with Luminal B breast cancer. Experts explain her breast...
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical...
Morningstar· 21 hours agoAtossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast ...
Promising Combination Therapy for Triple Negative Breast Cancer Treatment: A Milestone Collaboration...
Digital Journal· 19 hours ago(NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology ...
Breast Cancer Rates Skyrocketing in Young Canadian Women
Medscape· 2 days agoAs the Canadian Task Force on Preventive Health Care prepares to release its anticipated updated...
How 'The Good Doctor' Double Cliffhanger Set up Series Finale
TV Insider· 1 day agoThe penultimate episode of The Good Doctor just staged not one, but two massive cliffhangers in its...
... to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europe for...
FOX 4 Kansas City· 6 days agoSOC immune/chemotherapy alone in early-stage triple-negative breast cancer ("TNBC") in 54 patients in Switzerland and selected countries ...
Video: Treating breast cancer through surgery
Medical Xpress· 6 days agoGlobally, 2.3 million women are diagnosed with breast cancer every year, according to the World Health Organization. Advances in treating ...
Q1 2024 Bio Path Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 hours agoThese results are in line with previous work in which BP1003 plus gemcitabine...review of our first quarter financials, I'd like to highlight that we've strengthened our balance sheet in recent ...
Skipping Axillary Lymph Node Dissection in Breast Cancer?
Medscape· 2 days agoAxillary recurrence was rare among patients who skipped standard axillary lymph node dissection...
...Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress -...
Benzinga· 22 hours agoAcross 50 treated patients, palazestrant (OP-1250) in combination with ribociclib was well tolerated with no new safety signals or increased toxicity and no clinically meaningful impact on drug exposure of either
